Home / Europe / Bosnia and Herzegovina / Life Sciences & Healthcare

Life Sciences & Healthcare

With over 480 international specialist lawyers across CMS and the support of the Life Sciences Asia-Pacific Network (LAN), we understand the scientific and commercial as well as the legal imperatives affecting your life sciences & healthcare business. We work with and have established long-term relationships with the top 100 life sciences & healthcare companies in the areas of pharmaceuticals, medical devices, biotechnology, agriculture and food, including the top 20 global pharmaceutical companies and nine out of the top ten global medical device companies.

Our experts, many of whom have worked in-house in your sector, have developed a shared capability in the areas of pharmaceuticals, biotechnology, medical devices and diagnostics. With active memberships in major industry associations we help shape the legal frameworks impacting the life sciences & healthcare sector.

We regularly advise our clients on their day-to-day operational needs such as support with advertisement and promotion of medicine, public sector procurement, pricing and reimbursement, patent enforcement, commercial and clinical trial agreements as well as regulatory advice and compliance. Equally, when you need life sciences & healthcare specialist advice for strategic agreements, planning a corporate transaction or embarking on litigation (whether product liability or otherwise), we have a team that is well versed in the industry issues to help you.


Feed

20/03/2023
Out with the old, in with the new? Con­sid­er­a­tions for pat­entees in opt­ing...
So far in this series of blog posts, we began with an art­icle that high­lighted some of the key changes between the cur­rent European sys­tem of pat­ent pro­sec­u­tion and en­force­ment and the new Unit­ary Pat­ent...
09/03/2023
Se­cur­ity for costs in en­force­ment pro­ceed­ings in Ger­many – The Ger­man Fed­er­al...
Pur­su­ant to Sec. 110 of the Ger­man Civil Pro­ced­ure Code (ZPO), claimants who do not have their ha­bitu­al place of res­id­ence in a mem­ber state of the EU/the EEA can be ordered to provide se­cur­ity for the...
09/03/2023
CMS Ex­pert Guide to ESG Com­pens­a­tion
In­cor­por­at­ing ESG KPIs in­to dir­ect­ors’ re­mu­ner­a­tionThe ur­gent need to place sus­tain­ab­il­ity at the heart of com­pany strategy is in­ex­tric­ably linked to in­cent­ives provided to its dir­ect­ors and em­ploy­ees. This...
08/03/2023
Out with the old, in with the new? Pro­ced­ur­al fea­tures of the Uni­fied Pat­ent...
In our pre­vi­ous art­icle, we looked at the cur­rent European sys­tem of pat­ent pro­sec­u­tion and en­force­ment and high­lighted some of the key changes that will be com­ing with the new Unit­ary Pat­ent and Uni­fied...
06/03/2023
Fu­ture im­pact of emer­ging tech­no­lo­gies on IP pro­tec­tion and en­force­ment...
As tech­no­logy de­vel­ops rap­idly, the way in which stake­hold­ers pro­tect and en­force their in­tel­lec­tu­al prop­erty (IP) is chan­ging and will con­tin­ue to change in the fu­ture, but how? And should ex­ist­ing IP...
28/02/2023
New EU sanc­tions against Rus­sia
On 25 Feb­ru­ary 2023, one year after Rus­sia star­ted its in­va­sion of Ukraine, the EU ad­op­ted its tenth sanc­tions pack­age against Rus­sia. To­geth­er with the ex­ist­ing sanc­tions the European Com­mis­sion con­siders...
21/02/2023
UK reg­u­lat­or joins the glob­al en­force­ment trend and warns em­ploy­ers to...
The over­lap between em­ploy­ees’ rights and com­pet­i­tion law has long been pre­dicted by com­pet­i­tion spe­cial­ists. Car­tel en­force­ment in la­bour mar­ket agree­ments be­came a fledgling activ­ity of com­pet­i­tion...
20/02/2023
Sun­rise peri­od of the Uni­fied Pat­ent Court to be­gin 1 March
After the fi­nal ver­sion of the UPC Rules of Pro­ced­ure had been ad­op­ted and the judges of the UPC had been se­lec­ted and ap­poin­ted, the start of the Sun­rise Peri­od, ori­gin­ally planned for 1 Janu­ary 2023...
03/02/2023
On your radar | Is­sue 20 | Key em­ploy­ment is­sues to be aware of in­ter­na­tion­ally
Wel­come to the first edi­tion of On your radar for 2023, which high­lights ex­pec­ted em­ploy­ment law de­vel­op­ments over the year ahead.Changes range from big pic­ture con­cepts around fu­ture ways of work­ing...
12/12/2022
Glob­al Life Sci­ences & Health­care For­um 2022: Fa­cing the op­por­tun­it­ies...
Di­git­al ad­vances and in­nov­at­ive ther­apies are push­ing the bound­ar­ies of health and the leg­al world has to keep pace Life sci­ences are fizz­ing with in­genu­ity and in­nov­a­tion with re­volu­tion­ary gene and...
05/12/2022
EU Com­mis­sion pro­poses to mod­ern­ise product li­ab­il­ity rules for green and...
Cur­rent product li­ab­il­ity rules, based on the 85/374/EGK Product Li­ab­il­ity Dir­ect­ive (PLD), are nearly 40 years old and no longer suit­able for the mod­ern di­git­al age. Among oth­er things, the PLD is un­cer­tain...
22/11/2022
Glob­al Life Sci­ences & Health­care For­um 2022: Life Sci­ences are reap­ing...
Di­git­al trans­form­a­tion in life sci­ences is cre­at­ing op­por­tun­it­ies to counter health­care’s most in­tract­able prob­lems from treat­ing rare dis­eases to ac­cel­er­at­ing dia­gnostics and re­du­cing treat­ment back­logs...